LifeSignals UbiqVue 2A Monitoring System Earns FDA Clearance
LifeSignals’ UbiqVue 2A Multiparameter System wireless patient monitoring wearable has received FDA Class II 510(k) clearance.
LifeSignals’ UbiqVue 2A Multiparameter System wireless patient monitoring wearable has received FDA Class II 510(k) clearance.
Screening individuals for atrial fibrillation using wearable devices is more cost-effective than screening using conventional methods.
Use of 5G technology stands to vastly improve the healthcare industry’s capabilities via connected medical devices, wearables, and more.
LifeSignals’ UbiqVue 2A Multiparameter System wireless patient monitoring wearable has received FDA Class II 510(k) clearance.